ResearcherMount Sinai HospitalActive in the last 2 years
Celina Ang
Matched on ORCID iD 0000-0001-6057-6026; OpenAlex author ID A5014448224, A5053891144, A5108283808. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 18
2012: 1 paper · 2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper
Papers 5
- A Phase II Trial of an Extended-Release siRNA Implant Targeting KRASG12D/V in Locally Advanced Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-25-3189↗
- Major Postoperative Complications Limit Adjuvant Therapy Administration in Patients Undergoing Pancreatoduodenectomy for Distal Cholangiocarcinoma or Pancreati… Co-author DOI 10.1245/s10434-023-13533-0↗
- A single-institutional analysis of racial disparities in clinicopathologic characteristics, treatment selections, and outcomes in advanced-stage pancreatic can… Last author DOI 10.21037/apc-21-5↗
- Optimal chemotherapy dosing in a bilateral lower extremities amputee with metastatic pancreatic adenocarcinoma. Co-author PMID 23936551↗
- Communication and palliative care in a 64-year-old man with pancreatic adenocarcinoma. Co-author PMID 23077687↗
Closest collaborators
The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Eileen Mary O'Reilly · 3 shared papers, 2012–2026 · strength 0.29
- Paper A Phase II Trial of an Extended-Release siRNA Implant Targeting KRASG12D/V in Locally Advanced Pancreatic Cancer. DOI 10.1158/1078-0432.ccr-25-3189↗
- Paper Optimal chemotherapy dosing in a bilateral lower extremities amputee with metastatic pancreatic adenocarcinoma. PMID 23936551↗
- Paper Communication and palliative care in a 64-year-old man with pancreatic adenocarcinoma. PMID 23077687↗
- Milind M. Javle · 1 shared paper, 2026 · strength 0.22
- Anna M. Varghese · 1 shared paper, 2026 · strength 0.22
- Talia Golan · 1 shared paper, 2026 · strength 0.22
- Brinda Alagesan · 1 shared paper, 2026 · strength 0.22
- Wungki Park · 1 shared paper, 2026 · strength 0.22
- Manoop S. Bhutani · 1 shared paper, 2026 · strength 0.22
- Kenneth H. Yu · 1 shared paper, 2026 · strength 0.22
- Mark Andrew Schattner · 1 shared paper, 2026 · strength 0.22
- Matthew Adam Williams · 1 shared paper, 2021 · strength 0.19
- Rebekah Macfie · 1 shared paper, 2023 · strength 0.17
- Umut Sarpel · 1 shared paper, 2023 · strength 0.17
- Noah A. Cohen · 1 shared paper, 2023 · strength 0.17
- Ghassan K. Abou‐Alfa · 2 shared papers, 2012–2013 · strength 0.08
- Dwight Hall Owen · 1 shared paper, 2013 · strength 0.04
- Andrew S. Epstein · 1 shared paper, 2012 · strength 0.03
- Maeve Aine Lowery · 1 shared paper, 2012 · strength 0.03
- Ali I. Shamseddine · 1 shared paper, 2012 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.